Key Highlights

  • Afry AB reported Q2 earnings of $1.71 per share, missing the consensus estimate of $2.29.
  • Total sales fell 2.4% year-over-year, with organic sales growth declining 5.3%.
  • The company's order backlog increased 8% to SEK 22.4 billion.

Afry AB (NASDAQ: AFXXF) reported Q2 earnings of $1.71 per share, missing the consensus estimate of $2.29. The company's total sales fell 2.4% year-over-year, with organic sales growth declining 5.3%. Despite this, Afry AB's order backlog increased 8% to SEK 22.4 billion, indicating a potential rebound in future sales.

By the Numbers

Afry AB's Q2 earnings of $1.71 per share fell short of expectations, with the company's total sales declining 2.4% year-over-year. This decline was driven by a 5.3% decrease in organic sales growth. However, the company's order backlog increased 8% to SEK 22.4 billion, suggesting that Afry AB may be poised for a sales rebound in the future.

The company's EBITA margin amounted to 6.7%, indicating a relatively stable profitability profile.

Segment Detail

Afry AB's Q2 sales decline was driven by a combination of factors, including a decrease in organic sales growth. However, the company's order backlog increased 8% to SEK 22.4 billion, indicating that Afry AB may be gaining traction in its core markets. The company's EBITA margin remained relatively stable, amounting to 6.7% for the quarter.

Guidance

Afry AB's Q2 earnings miss and sales decline may raise concerns about the company's future growth prospects. However, the company's increasing order backlog and stable profitability profile suggest that Afry AB may be well-positioned for a rebound in the future. Investors will be watching closely to see if the company can deliver on its growth potential in the coming quarters.

Next Catalyst

Afry AB's Q2 earnings report has set the stage for a potentially volatile trading environment in the coming weeks. Investors will be watching closely to see if the company can deliver on its growth potential in the coming quarters. The company's next earnings report, scheduled for October 2026, will be a key catalyst for the stock.

Based on the Q2 earnings report released 15 July 2026.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.